NexStep Biomarkers, LLC. was founded in 2007 by David M. Devilbiss Ph.D. to provide custom laboratory services to meet the needs of basic research and drug discovery programs. Our goal at NexStep Biomarkers is to provide: 1) non-commercially available software, scripts, and routines as well as enterprise solutions and 2) biological markers of CNS compound efficacy and action through physiologically relevant in vivo models. The people of NexStep Biomarkers include neuroscientists, programmers, and engineers with expertise in designing custom electrophysiological analysis software (for spike trains, EEG, and ERPs), models of animal behavior, and determining the neurobiological mechanisms underlying compound actions.
